The clinician decides to continue treatment and discusses augmentation to address persistent anhedonia and low motivation. Ms. L has had two previous depressive episodes. Why is full remission particularly important in this patient?

A patient with major depressive disorder and prominent anxiety is treated with a medication that blocks 5HT2A, H1, and α1 receptors. Which combination of therapeutic and adverse effects is most likely?

Which best explains why monotherapy is often insufficient in bipolar disorder?  

A patient with depression reports persistent guilt, negative self-focus, and repetitive rumination. Energy is preserved. Anxiety is moderate. Which option best reflects the dominant neurotransmitter imbalance and mechanism-based selection?

A patient reports difficulty organizing tasks, impaired working memory, and indecisiveness. Mood has partially improved. Which circuit region is most directly associated with these persistent symptoms?

A 31-year-old patient presents with: Depressed mood Severe rumination Excessive guilt Insomnia Marked hypervigilance Episodic panic symptoms History reveals one prior episode of decreased need for sleep and increased goal-directed behavior lasting 5 days. Which option best integrates diagnosis and mechanism-based treatment?

Match each receptor-level mechanism (Column A) with the most appropriate therapeutic effect. Each mechanism will be used once.

A patient with depression and low energy is started on an SNRI. She reports improved concentration but also develops mild insomnia and increased heart rate. Which mechanism best explains both effects?

The clinician explains that recurrent mood episodes can increase vulnerability to future episodes. Which concept best supports continued maintenance treatment?

A patient with major depressive disorder presents with persistent rumination, excessive worry, and autonomic hyperarousal. Functional imaging studies in similar patients most consistently demonstrate: